Get the content you want anytime you want.

Latest News From Contagion® Live

Latest News

MSM Whose Partners Use PrEP Could Have Greater Risk for STI
The prevalence of sexually transmitted infections is rising, and a new study suggests a higher risk for HIV-positive MSM whose partners use PrEP.
32 Hepatitis A Outbreaks Linked to Drinking Water Identified From 1971-2017
Although drinking water-associated outbreaks are rarely reported in the United States, they were the most commonly reported etiology for outbreaks associated with untreated ground water from 1971-2008.
Bundling PrEP With Family Planning May Be Key to HIV Prevention
A study conducted in Kenya demonstrated that appealing to women who present at family-planning clinics to obtain birth control can increase the percentage who will use PrEP.
Leprosy Outbreak in United States Only a 'Matter of Time,' One Physician Argues
Even though leprosy is not widespread in the United States, the current landscape in some cities, such as Los Angeles, is creating the perfect environment for so-called “ancient” diseases to flourish.
Sepsis Responsible for Nearly a Quarter of Maternal Deaths
Study investigators assessed the nationwide incidence of sepsis within 42 days of delivery discharge.
The Future of Duodenoscopes—FDA Pushes for Disposable Components
Following outbreaks and disinfecting failures, new recommendations advocate for duodenoscopes with disposable components seek to drive change in reducing risk of patient infections.
Novel Drug Combination Noninferior for Treatment of cUTI
A novel combination of ceftriaxone, sulbactam and disodium EDTA (CSE) was found noninferior to meropenem to treat cUTIs caused by gram-negative pathogens.
<i>Contagion</i>® Connect Episode 2: 'The Most Expensive Drug Is the One That Doesn't Work'
In this episode, we take a dual look at the recently announced changes to antibiotic reimbursements from the Centers for Medicare and Medicaid Services from both the clinician and industry perspective.
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?